Smith & Nephew plc - ADR

Smith & Nephew plc - ADR

SNN

Get informed when a big investor buys or sells

+ Follow
Market Cap$12.9B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Smith & Nephew plc - ADRSmith & Nephew plc - ADR20.32.55%22%1.10.7
$33.88

Target Price by Analysts

9.9% upsideSmith & Nephew plc Target Price DetailsTarget Price
$16.74

Current Fair Value

45.7% downside

Overvalued by 45.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.90 Billion
Enterprise Value$15.93 Billion
Dividend Yield$0.79 (2.55%)
Earnings per Share$1.46
Beta0.69
Outstanding Shares430,397,727

Return

Return on Equity21.77%ROE
Return on Assets10.24%
Return on Invested Capital19.89%

Valuation & Multiples

P/E Ratio20.29P/E Ratio
PEG815.61PEG
Price to Sales1.1Price to Sales
Price to Book Ratio2.57Price to Book Ratio
Enterprise Value to Revenue1.3
Enterprise Value to EBIT8.94
Enterprise Value to Net Income14
Total Debt to Enterprise0.24
Debt to Equity0.73Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$0.94
Average shareholder expectation
Revenue Estimate
$3.46 B
Average shareholder expectation

Next Earnings Call

Expected Date
February 23, 2027
EPS Estimate
$1.21
Average shareholder expectation
Revenue Estimate
$3.32 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.15%▼ 8.36%
Total Invested$17.43M▼ 98.35%
Investors Holding27▼ 269.00%

ESG Score

No data

About Smith & Nephew plc

18,362 employees
CEO: Roland Diggelmann

Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for jo...